Hepatitis B virus binding to leucocyte plasma membranes utilizes a different region of the preS1 domain to the hepatocyte receptor binding site and does not require receptors for opsonins

Immunology and Cell Biology

Volumn 75, Issue 3, 1997, Pages 259-266

  Atkins, Gerald J ^a,b   Qiao, Ming ^b   Coombe, Deirdre R ^c   Gowans, Eric J ^d   Ashman, Leonie K ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Glycosaminoglycan; Hepatitis B virus; Leucocyte; Opsonin; Plasma membranes; Receptor

Indexed keywords

GLYCOSAMINOGLYCAN; IMMUNOGLOBULIN A; OPSONIN; VIRUS RECEPTOR;

ARTICLE; CONTROLLED STUDY; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LEUKOCYTE MEMBRANE; MONONUCLEAR CELL; NEUTROPHIL; NORMAL HUMAN; RECEPTOR BINDING; VIRUS ADSORPTION; VIRUS CELL INTERACTION;

HEPATITIS B VIRUS;

EID: 0030788068     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1038/icb.1997.40     Document Type: Article

References (52)

1. Ganem D, Varmus HE. The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem. 1987; 56: 651-93.
2. Lamelin JP, Trepo C. The hepatitis B virus and the peripheral blood mononuclear cells: a brief review. J. Hepatol. 1990; 10: 120-4.
3. Yoffe B, Noonan CA, Melnick JL, Hollinger FB. Hepatitis B virus DNA in mononuclear cells and analysis of cell subsets for the presence of replicative intermediates of viral DNA. J. Infect. Dis. 1986; 153: 471-7.
4. Romet-Lemonne JL, McLane MF, Elfassi E, Haseltine WA, Azocar J, Essex M. Hepatitis B virus infection in cultured human lymphoblastoid cells. Science 1983; 221: 667-9.
5. Shen HD, Choo KB, Wu TC, Ng HT, Han SH. Hepatitis B virus infection of cord blood leukocytes. J. Med. Virol. 1987; 22: 211-16.
6. Peterson DL. Isolation and characterization of the major protein and glycoprotein of hepatitis B surface antigen. J. Biol. Chem. 1981; 256: 6975-83.
7. Heermann KH, Goldmann U, Schwarz W, Seyffrath T, Baumgarten H, Gerlich WH. Large surface proteins of hepatitis B virus containing the pre-S sequence. J. Virol. 1984; 52: 396-402.
8. Budkowska A, Dubreuil P, Gerlich WH, Lazizi Y, Pillot J. Occurrence of preS1 antigen in viremic and nonviremic carriers of hepatitis B surface antigen. J. Med. Virol. 1988; 26: 217-25.
9. Pontisso P, Petit MA, Bankowski MJ, Peeples ME. Human liver plasma membranes contain receptors for the hepatitis B virus preS1 region and, via polymerised human serum albumin, for the preS2 region. J. Virol. 1989; 63: 1981-8.
10. Treichei T, Meyer zum Bushenfelde KH, Stockert RJ, Poralla T, Gerken G. Binding and uptake of hepatitis B virus by the asialoglycoprotein receptor (ASGPR) in vitro (abstract). Hepatology 1992; 16 (Suppl. 2): A103.
11. Neurath AR, Strick N. Antigenic mimicry of an immunoglobulin A epitope by a hepatitis B virus cell attachment site. Virology 1990; 178: 631-4.
12. Neurath AR, Strick N, Sproul P. Search for hepatitis B virus cell receptors reveals binding sites for interleukin 6 on the virus envelope protein. J. Exp. Med. 1992; 175: 461-9.
13. Budkowska A, Quan C, Groh F et al. Hepatitis B virus (HBV) binding factor in human serum: candidate for a soluble form of hepatocyte HBV receptor. J. Virol. 1993; 67: 4316-22.
14. Hertogs K, Leenders W, De Bruin W et al. Endonexin II. present on human liver plasma membranes, is a specific binding protein of small hepatitis B virus envelope protein. Virology 1993; 197: 549-57.
15. Mehdi H, Kaplan MJ, Anlar FY et al. Hepatitis B virus surface antigen binds to apolipoprotein H. J. Virol. 1994; 68: 2415-24.
16. Franco A, Paroli M, Testa U et al. Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes. J. Exp. Med. 1992; 175: 1195-205.
17. Neurath AR, Strick N. The putative cell receptors for hepatitis B virus (HBV), annexin V and apolipoprotein H, bind to lipid components of HBV. Virology 1994; 204: 475-7.
18. Burrell CJ. Host components in hepatitis B antigen. J. Gen. Virol. 1975; 27: 117-26.
19. Guyre PM, Graziano RF, Vance BA, Morganelli PM, Fanger MW. Monoclonal antibodies define two epitopes which trigger human FcγR1 function. J. Immunol. 1989; 143: 1650-5.
20. Looney RJ, Abraham GN, Anderson CL. Human monocytes and U937 cells bear two distinct receptors for IgG. J. Immunol. 1986; 136: 1641-7.
21. Fleit HB, Wright SD, Unkeless JC. Human neutrophil Fc-γ receptor distribution and structure. Proc. Natl Acad. Sci. USA 1982; 79: 3275-9.
22. Shen L, Lasser R, Fanger MW. My43, a monoclonal antibody that reacts with human myeloid cells, inhibits monocyte IgA binding and triggers function. J. Immunol. 1989; 143: 4117-22.
23. Lyons AB, Cooper SJ, Cole SR, Ashman LK. Human myeloid differentiation antigens identified by monoclonal antibodies to the myelomonocytic leukemia cell line RC-2A. Pathology 1988; 20: 137-46.
24. Diamond MS, Garcia-Aguilar J, Bickford JK, Corbi AL, Springer TA. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J. Cell Biol. 1993; 120: 1031-43.
25. Sanchez-Madrid F, Krensky AM, Ware CF et al. Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc. Natl Acad. Sci. USA 1982; 79: 7489-93.
26. Petit MA, Dubanchet S, Capel F. A monoclonal antibody specific for the hepatocyte receptor binding site on hepatitis B virus. Mol. Immunol. 1989; 26: 531-7.
27. O'Connor CG, Ashman LK. Application of the nitrocellulose transfer technique and alkaline phosphatase conjugated antiimmunoglobulin for determination of the specificity of monoclonal antibodies to protein mixtures. J. Immunol. Methods 1982; 54: 267-71.
28. Ferrante A, Thong YH. Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the Hypaque-Ficoll method. J. Immunol. Methods 1980; 36: 109-17.
29. Hubbard AL, Wall DA, Ma M. Isolation of rat hepatocyte plasma membranes: Presence of three major domains. J. Cell Biol. 1983; 96: 217-29.
30. Standring R, Williams AF. Glycoproteins and antigens of membranes prepared from rat thymocytes after lysis by shearing or with the detergent Tween-40. Biochim. Biophys. Acta 1978; 508: 85-96.
31. Ey PL, Ferber E. Calf thymus alkaline phosphatase II: Properties of the membrane-bound enzyme. Biochim. Biophys. Acta 1977; 480: 403-16.
32. Crumpton MJ, Snary D. Preparation and properties of lymphocyte plasma membrane. Contemp. Top. Mol. Immunol. 1975; 3: 27-56.
33. 125I-labelled human growth hormone of high specific activity. Biochem. J. 1963; 89: 114-23.
34. Qiao M, MacNaughton TB, Gowans EJ. Adsorption and penetration of Hepatitis B virus in a nonpermissive cell line. Virology 1994; 201: 356-63.
35. Pontisso P, Ruvoletto C, Tiribelli C, Gerlich WH, Ruol A, Alberti A. The preS1 domain of hepatitis B virus and IgA cross-react in their binding to the hepatocyte surface. J. Gen. Virol. 1992; 73: 2041-5.
36. Okamoto H, Imai M, Usuda S et al. Hemagglutination assay of polypeptide coded by the pre-S region of hepatitis B virus DNA with monoclonal antibody: correlation of pre-S polypeptide with the receptor for polymerized human serum albumin in serums containing hepatitis B antigens. J. Immunol. 1985; 134: 1212-16.
37. Halstead SB, O'Rourke EJ. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 1977; 265: 739-41.
38. Peiris JSM, Porterfield JS. Antibody-mediated enhancement of flavivirus replication in macrophage-like cell lines. Nature 1979; 282: 509-11.
39. Webster RG, Askonas BA. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur. J. Immunol. 1980; 10: 396-401.
40. Delibrias CC, Kazatchkine MD, Fischer E. Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV. Scand. J. Immunol. 1993; 38: 183-9.
41. Takeda A, Sweet RS, Ennis FA. Two receptors are required for antibody-dependent enhancement of human immunodeficiency virus type I infection: CD4 and FcγR. J. Virol. 1990; 64: 5605-10.
42. Maliszewski CR, March CJ, Schoenborn MA, Gimpel S, Shen L. Expression cloning of a human Fc receptor for IgA. J. Exp. Med. 1990; 172: 1665-72.
43. Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro A, Fearon DT. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl Acad. Sci. USA 1984; 81: 4510-14.
44. Vetvicka V, Ross GD. Blockade of C3d receptor activity by mAbs. In: Schlossman SF et al. (ed.) Leukocyte Typing V: White Cell Differentiation Antigens. Proceedings of the Fifth International Workshop and Conference. Oxford: Oxford University Press, 1995; 520-1.
45. Ross GD, Vetvicka V, Thornton BP, Vetvicka J. CD35 (CR1) cluster workshop report. In: Schlossman SF et al. (ed.) Leukocyte Typing V: White Cell Differentiation Antigens. Proceedings of the Fifth International Workshop and Conference. Oxford: Oxford University Press, 1995; 871-4.
46. Pontisso P, Morsica G, Ruvoletto MG, Zambello R, Colletta C, Alberti A. Hepatitis B virus binds to peripheral blood mononuclear cells via the preS1 domain. J. Hepatol. 1991; 12: 203-6.
47. Rider CC, Coombe DR, Harrop HA et al. Anti-HIV-1 activity of chemically modified heparins: correlation between binding to the V3 loop of gp120 and inhibition of cellular HIV-1 infection in vitro. Biochemistry 1994; 33: 6974-80.
48. Price P, Allcock RJN, Coombe DR, Shellam GR, McCluskey J. MHC proteins and heparan sulphate proteoglycans influence murin ecytomegalovirus infection. Immunol. Cell Biol. 1995; 73: 308-15.
49. Budkowska A, Bedossa P, Groh F, Louise A, Pillot J. Fibronectin of human liver sinusoids binds hepatitis B virus: Identification by an anti-idiotypic antibody bearing the internal image of the preS2 domain. J. Virol. 1995; 69: 840-8.
50. Zeldis JB, Mugishima H, Steinberg HN, Nir E, Gale RP. In vitro hepatitis B virus infection of human bone marrow cells. J. Clin. Invest. 1986; 78: 411-17.
51. Erbe DV, Collins JE, Shen L, Graziano RF, Fanger MW. The effect of cytokines on the expression and function of Fc receptors for IgG on human myeloid cells. Mol. Immunol. 1990; 27: 57-67.
52. Te Velde AA, Klomp JPG, Yard BA, de Vries JE, Figdor CG. Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. J. Immunol. 1988; 140: 1548-54.